Richard S. Lindahl - 15 Oct 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role: EVP, Chief Financial Officer
Signature: /s/ Richard S. Lindahl
Issuer symbol: EBS
Transactions as of: 15 Oct 2024
Net transactions value: $0
Form type: 4
Filing time: 17 Oct 2024, 17:04:36 UTC
Previous filing: 11 Jun 2024
Next filing: 13 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EBS	Common Stock	Award	$0	+15,000	+9.6%	$0.000000	171,009	15 Oct 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in one annual installment beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

Content

Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in one annual installment beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.